Eli Lilly Strikes $375M Covid-19 Antibody Supply Deal With US Government
Stocks Struggle To Stabilize After Worst Rout Since June
Gilead Q3 revenue rise bolstered by $873m Veklury sales
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday
Gilead Cuts 2020 Guidance As Remdesivir Sales Disappoint
Regeneron’s Covid-19 antibody treatment cut medical visits in trial
Gilead cuts 2020 sales outlook as Covid-19 drug remdesivir falls short
Osteoporosis drug helps Amgen third-quarter 2020 profit beat estimates
COVID stress syndrome: 5 ways the pandemic is affecting mental health
US buys Lilly COVID antibody, as effectiveness questions remain
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly
ESG Risks And Opportunities In Credit Ratings
Sanofi, GSK to supply vaccine doses to WHO-backed alliance
U.S. strikes deal with Lilly for potential Covid-19 antibody drug
Novartis Harnesses Molecular Partners’ DARPin Technology Against Covid-19
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday;
News briefing: SpringWorks, Jazz exchange $35M and PTSD drug; Dr. Reddy's says cyberattack was ransomware
Mental illness and substance use: the two often go hand in hand so why is it so difficult to get help?
Covid-19 roundup: Novavax delays PhIII trial in US, with PhII data coming Friday; CBER director promises 'safe and effective' vaccine in op-ed
Mindlessness Fuels Tyranny
US Hospitalizations Soar Almost 40% In One Week; Wisconsin Sees New COVID-19 Record: Live Updates
5 startup theses that will transform the 2020s
Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day
Identifying potential anti-COVID-19 pharmacological components of TCM
Eli Lilly Ends Covid-19 Trial In Hospitalized Patients On Disappointing Data
Futures Rebound From Monday's Plunge On Strong Earnings, Mega Merger
France Weighs Return To Lockdown As Russia Refuses Despite Spike In COVID-19 Cases, Deaths: Live Updates
Patrick Soon-Shiong steps down as CEO of NantKwest, a linchpin of his 'Cancer Moonshot'
"Tremendous News!" - Maduro Touts Venezuelan Vaccine That Inhibits COVID
Identifying hotspots of low mammography screening in Black, Hispanic women